Taehyung S. Kim

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabine.

Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabine.

Journal: Hematology (Amsterdam, Netherlands)
Published: March 04, 2024

Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes.

Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes.

Journal: Blood advances
Published: November 13, 2023

Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia.

Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia.

Journal: Scientific reports
Published: June 22, 2023

The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine.

The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine.

Journal: The Korean journal of internal medicine
Published: December 17, 2022

Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia.

Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia.

Journal: Cancer research and treatment
Published: October 25, 2022

Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up.

Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up.

Journal: Haematologica
Published: July 24, 2022

A 5-microRNA signature derived from core binding factor-AML is predictive in adult and childhood AML.

A 5-microRNA signature derived from core binding factor-AML is predictive in adult and childhood AML.

Journal: Leukemia research
Published: June 01, 2022

The 17-gene stemness score associates with relapse risk and long-term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia.

The 17-gene stemness score associates with relapse risk and long-term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia.

Journal: EJHaem
Published: February 07, 2022

Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia.

Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia.

Journal: Bone marrow transplantation
Published: January 14, 2022

Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase Inhibitors.

Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase Inhibitors.

Journal: Cancers
Published: September 24, 2021

Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasms.

Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasms.

Journal: Leukemia research
Published: August 09, 2021

BCR-ABL1 transcript doubling time as a predictor for treatment-free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase.

BCR-ABL1 transcript doubling time as a predictor for treatment-free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase.

Journal: British journal of haematology
Published: June 01, 2021
Showing 1-12 of 34

Last Updated: 09/26/2026